SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-010974
Filing Date
2021-08-09
Accepted
2021-08-09 16:11:44
Documents
65
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q omer-20210630x10q.htm   iXBRL 10-Q 1260821
2 EX-10.1 omer-20210630xex10d1.htm EX-10.1 46990
3 EX-31.1 omer-20210630xex31d1.htm EX-31.1 11337
4 EX-31.2 omer-20210630xex31d2.htm EX-31.2 12524
5 EX-32.1 omer-20210630xex32d1.htm EX-32.1 8105
6 EX-32.2 omer-20210630xex32d2.htm EX-32.2 7656
7 GRAPHIC omer-20210630x10q006.jpg GRAPHIC 40842
  Complete submission text file 0001558370-21-010974.txt   6304307

Data Files

Seq Description Document Type Size
8 EX-101.SCH omer-20210630.xsd EX-101.SCH 35201
9 EX-101.CAL omer-20210630_cal.xml EX-101.CAL 49950
10 EX-101.DEF omer-20210630_def.xml EX-101.DEF 118099
11 EX-101.LAB omer-20210630_lab.xml EX-101.LAB 378302
12 EX-101.PRE omer-20210630_pre.xml EX-101.PRE 273097
13 EXTRACTED XBRL INSTANCE DOCUMENT omer-20210630x10q_htm.xml XML 1334611
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

IRS No.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34475 | Film No.: 211156597
SIC: 2834 Pharmaceutical Preparations